Close
Show
Home Press Releases

Press Releases

Press Releases is unique and effective promotional tool offered from Worldpharmatoday.com aimed at bringing our client’s business message into limelight and more importantly make it reach their target audience. This feature can be utilized to launch new product, promoting existing Pharma product, publish business agreements, annual reports, financial results, corporate performances, important announcements or any important information that has to be conveyed to the target audience.

Merck and Transylvanian Institute of Neuroscience Cooperate on Brain-Inspired Artificial Intelligence

Merck and Transylvanian Institute of Neuroscience Cooperate on Brain-Inspired Artificial Intelligence


Merck, a leading science and technology company,  announced a three-year collaboration with the Transylvanian Institute...
Sanofi and GSK initiate Phase 1/2 clinical trial of COVID-19 adjuvanted recombinant protein-based vaccine candidate

Sanofi and GSK initiate new Phase 2 study of their adjuvanted recombinant protein-based COVID-19...


Sanofi and GSK announced the initiation of a new Phase 2 study with 720 volunteers...
RedHill Biopharma Strengthens Partnership with Cosmo Pharmaceuticals with Manufacturing Agreements for Movantik and RHB-204

RedHill Biopharma Strengthens Partnership with Cosmo Pharmaceuticals with Manufacturing Agreements for Movantik and RHB-204


RedHill Biopharma Ltd., a specialty biopharmaceutical company, announced agreements with Cosmo Pharmaceuticals NV to manufacture...
AstraZeneca's COVID-19 vaccine authorised for emergency supply in the UK

AstraZeneca COVID-19 vaccine authorised for emergency use by the World Health Organization


AstraZeneca’s COVID-19 vaccine has been granted Emergency Use Listing (EUL) by the World Health Organization...
KSTP and AstraZeneca Launch Co-incubation Programme for Biomedical Startups to Develop Made in HK Integrated Oncology Solutions

HKSTP and AstraZeneca Launch Co-incubation Programme for Biomedical Startups to Develop Made in HK...


AstraZeneca and the Hong Kong Science and Technology Parks Corporation (HKSTP) have launched a co-incubation...

Catalent Signs Development and Manufacturing Agreement with Trizell for Macrophage-based Advanced Cell Therapy


Catalent, the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs,...
Lonza Partners with Cryoport and Strengthens its Vein-to-vein Delivery Network in Cell & Gene Therapy

Lonza Announces High-Quality Cryopreserved Leukopaks for More Flexibility in Immunology and Cell Therapy Research


Lonza has expanded its renowned human primary cell offerings with the launch of fully customizable,...
AstraZeneca's Forxiga approved in China for heart failure

AstraZeneca’s Forxiga approved in China for heart failure


AstraZeneca’s Forxiga has been approved in China to reduce the risk of cardiovascular (CV) death...
Bayer receives approval for Nubeqa in China for the treatment of men with non-metastatic castration-resistant prostate cancer

Bayer receives approval for Nubeqa in China for the treatment of men with non-metastatic...


The Chinese National Medical Products Administration (NMPA) has approved Nubeqa for the treatment of patients...
Vaxart Announces Positive Preliminary Data from Phase 1 Clinical Trial Evaluating Its Oral COVID-19 Tablet Vaccine Candidate

Vaxart Announces Positive Preliminary Data from Phase 1 Clinical Trial Evaluating Its Oral COVID-19...


Vaxart, Inc., a clinical-stage biotechnology company developing oral vaccines administered by tablet, announced preliminary data...